Literature DB >> 12356836

Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.

Renu A Kowluru1, Prashant Koppolu.   

Abstract

PURPOSE: To investigate the effect of termination of galactose feeding after a very short duration of experimental galactosemia on the biochemical abnormalities that are postulated to contribute to the development of retinopathy.
METHODS: Experimentally galactosemic rats (normal rats fed a 30% galactose-rich diet for 2 months) were fed a galactose-free diet for an additional 1 month. At the end of 3 months, retinas were removed to measure oxidative stress, nitric oxides (NOs), activity of PKC, and levels of nitrotyrosine. Data were compared between rats in the control group (fed a normal diet) and those in the experimentally galactosemic group (30% galactose diet for the entire 3 months).
RESULTS: Interruption of 2 months of galactose feeding by withdrawal of galactose from the diet for 1 additional month had partially beneficial effects on retinal lipid peroxides, but the levels of an endogenous antioxidant, reduced glutathione (GSH), remained subnormal in the retina of galactose-withdrawal rats (P < 0.05 vs. normal and P > 0.05 vs. galactose group). Cessation of the galactose-rich diet had partially beneficial effects on NO levels in the retina, but the levels of nitrotyrosine, an indicator of the formation of peroxynitrite, and activation of PKC were not affected.
CONCLUSIONS: The results show that retinal dysmetabolism continues to progress after experimental galactosemia is terminated in rats: Particularly, antioxidant levels remain subnormal, and nitrotyrosine levels are elevated for at least 1 month. Identification of metabolic abnormalities associated with the progression of incipient retinopathy after hyperglycemia is normalized may help in the search for the cause of retinopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356836

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.

Authors:  Pooi-See Chan; Mamta Kanwar; Renu A Kowluru
Journal:  J Diabetes Complications       Date:  2008-12-03       Impact factor: 2.852

Review 2.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

3.  Metabolic memory in diabetes - from in vitro oddity to in vivo problem: role of apoptosis.

Authors:  Renu A Kowluru; Pooi-See Chan
Journal:  Brain Res Bull       Date:  2009-05-20       Impact factor: 4.077

4.  Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy.

Authors:  Raffaele Mancino; Donato Di Pierro; Chiara Varesi; Angelica Cerulli; Alessandra Feraco; Claudio Cedrone; Maria Dolores Pinazo-Duran; Massimiliano Coletta; Carlo Nucci
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

5.  Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy.

Authors:  Mamta Kanwar; Renu A Kowluru
Journal:  Diabetes       Date:  2008-10-13       Impact factor: 9.461

Review 6.  Oxidative stress and diabetic retinopathy.

Authors:  Renu A Kowluru; Pooi-See Chan
Journal:  Exp Diabetes Res       Date:  2007

7.  Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries.

Authors:  Renu A Kowluru; Mamta Kanwar; Alexander Kennedy
Journal:  Exp Diabetes Res       Date:  2007

Review 8.  Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases.

Authors:  Ankita Nandi; Liang-Jun Yan; Chandan Kumar Jana; Nilanjana Das
Journal:  Oxid Med Cell Longev       Date:  2019-11-11       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.